MUSTANG BIO, INC. Repayments of Related Party Debt
MUSTANG BIO, INC. (MBIO) reported Repayments of Related Party Debt of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2022-03-23
- MUSTANG BIO, INC. repayments of related party debt for the quarter ending 2018-12-31 was $0.00.
- MUSTANG BIO, INC. repayments of related party debt for the quarter ending 2018-09-30 was $0.00.
- MUSTANG BIO, INC. repayments of related party debt for the quarter ending 2018-06-30 was $0.00.
- MUSTANG BIO, INC. repayments of related party debt for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. repayments of related party debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- MUSTANG BIO, INC. repayments of related party debt for fiscal 2020 was $15.75M.
- MUSTANG BIO, INC. repayments of related party debt for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- MUSTANG BIO, INC. repayments of related party debt for fiscal 2017 was $320.00K, a 84.01% decline from fiscal 2016.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 10 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-23 | ||||
| 2020-12-31 | $15.75M 10-K · filed 2022-03-23 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $0.00 10-K · filed 2019-03-18 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | $0.00 derived: sum of 4 quarters · filed 2019-03-18 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $0.00 derived: sum of 4 quarters · filed 2019-03-18 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $0.00 derived: sum of 4 quarters · filed 2019-03-18 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $320.00K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $320.00K 10-Q · filed 2018-11-13 | -$1.21M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $320.00K 10-Q · filed 2018-08-13 | -$1.21M derived: sum of 3 quarters · filed 2018-08-13 | $2.32M derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | $320.00K 10-Q · filed 2018-05-14 | -$1.21M derived: sum of 2 quarters · filed 2018-05-14 | $2.32M derived: sum of 3 quarters · filed 2018-05-14 | $2.32M derived: sum of 4 quarters · filed 2018-05-14 | |
| 2016-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $2.00M derived: sum of 2 quarters · filed 2018-03-29 | $2.00M derived: sum of 3 quarters · filed 2018-03-29 | $2.00M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $3.53M derived: sum of 2 quarters · filed 2017-11-14 | $3.53M 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |